Olivier Elemento

Register today for our next @WCMEnglanderIPM #AI Clinic, led by EIPM Member Dr. Iman Hajirasouliha (@hajirasouliha), on "Using #LLMs and #AI Paper-Review Tools to Revise Scientific Manuscripts: A Case Study on Generating Synthetic Human #Blastocyst Images," on March 25th!

Big news: the thymus may be critical for adult health What if we missed something fundamental about the immune system? In two back-to-back papers in Nature, we show thymic health (AI on 30,000+ CT scans) links to longevity, disease risk & immunotherapy outcomes.

Check out the new article, "The Cornell Health #AI Hackathon Showed Me What the Future of #Healthcare Could Look Like," by @WCMEnglanderIPM's Alex Sigaras (@AlexSigaras), Ass't Prof. of Research in Systems and Computational Biomedicine @WeillCornell! linkedin.com/pulse/cornell-…

How specific are therapeutic monoclonal antibodies, really? In our new paper, @Yile_Dai led a collaboration with Adimab to profile 174 FDA-approved and clinical-stage mAbs against 6,172 human extracellular proteins. What we found surprised us.🧵 sciencedirect.com/science/articl…

New! LLM Thematic Generalization Benchmark V2! Models see 3 examples, 3 misleading anti-examples and 8 candidates with exactly 1 hidden correct answer. The theme is hidden. Can they infer the narrow latent rule instead of falling for the broader pattern?

New OpenFold3 preview out! (OF3p2) It closes the gap to AlphaFold3 for most modalities. Most critically, we're releasing everything, including training sets & configs, making OF3p2 the only current AF3-based model that is functionally trainable & reproducible from scratch🧵1/9

Congrats to Scientific Director Dr. Massimo Cristofanilli (@MassimoCristof09) & Dr. Carolina Reduzzi (@ReduzziCarol) on their new @ScienceTMpaper, "Dual-positive #CTCs in patients with advanced #breastcancer show metastatic potential and prognostic value." science.org/doi/10.1126/sc…

Very grateful that our paper: The interplay between mutagenesis and extrachromosomal DNA shapes urothelial cancer evolution received the 2026 EAU Best Paper on Fundamental Research Award. @Uroweb nature.com/articles/s4158… I will be at #EAU26 in London and look forward to seeing friends and colleagues. If you want to talk science, #BladderCancer, or cancer evolution, let's connect. #TeamScience

💊💊💊 @Ginkgo just dropped GDPx4 💊💊💊 29.9 MILLION rows of DRUG-seq data, perfect for benchmarking + large-scale perturbation modeling critical for anyone who can't afford their own high-throughput lab a little more in 🧵

Study in @NatureComms Identifies Gene Linked to #Chemotherapy Resistance in #ProstateCancer. “The research opens the door to future therapies that could block resistance and restore drug effectiveness,” said @WCMEnglanderIPM's Dr. Paraskevi Giannakakou. news.weill.cornell.edu/news/2026/03/s…

We hope you enjoy "A Conversation with Dr. Benjamin Hopkins," (@Degreesofhealth) the @WCMEnglanderIPM's Director of Ex Vivo Models, on #organoids #colorectal cancer #ovariancancer #immunology #breastcancer and improving immune responses in patients! youtu.be/C5DEuXVMTSU

Congratulations to @WCMEnglanderIPM's Clinical Director Dr. Cora Sternberg (@cnsternberg) on her new paper in the @OncJournal, "Molecular Landscape of #ProstateCancers with #ClivalMetastases." #google_vignette" target="_blank" rel="nofollow noopener">academic.oup.com/oncolo/advance…

Learn about "Scalable Implementation of #Imaging #AI Tools in the Clinic," with Eeshaan Rehani (@eeshaanreh) from Dr. Iman Hajirasoulih's lab (@hajirasouliha) at the next @WCMEnglanderIPM #AI Clinic!

Congrats to our @WCMEnglanderIPM colleague Dr. Ekta Khurana (@ekta_khurana) on earning a $1 million Award from the Prostate Cancer Foundation (@PCFnews) to develop an #AI-based method for early detection of treatment-resistant #prostatecancer! news.weill.cornell.edu/news/2026/03/w…

Proud to be part of this new CRUK cancer grand challenge team REWIRE-CAN with colleagues Chris Tape and Bart Vanhaesebroeck from @ucl @broadinstitute @MSKCancerCenter @UUBeta !! Our team plans to reprogram cancer cells into vulnerable states by disrupting their finely tuned “Goldilocks” level of oncogenic signalling. See more at cancergrandchallenges.org/rewire-can

It got me at "across all domains of life" Predicting pathogenicity of non-coding regions, produces sequences at genome scale, and much more Evo 2, open-source, @Nature today @arcinstitute @pdhsu @BrianHie nature.com/articles/s4158…

So excited to share our latest work with @PedramRazaviMD, @MSKCancerCenter, and Sarat Chandarlapaty out today in @Nature. nature.com/articles/s4158… (1/n)

Evo 2, our fully open-source biological foundation model trained on trillions of DNA tokens spanning the entire tree of life, is out in @Nature today We & the scientific community have done a lot with this @arcinstitute @nvidia model in the last year! 🧵👇

Join us two weeks from Thursday for an @WCMEnglanderIPM #PrecisionMedicine Research Conference featuring Research #Pathology Fellows Drs. Eda Nur Kozan and Jesus Delgado De La Mora from @WCMCPathology! #NRG1 #WGS #FusionCarcinoma #CancerResearch

While a 20% overall response rate, is not the kind of thing that makes a big splash in NEJM, there's reason to be very excited about this. The "impossible" label on TP53 has been ripped off. This is just the first of what I think will be many p53-targeted compounds to come.